E5501 - Phase II Study of Topotecan Sequenced with Etoposide/Cisplatin, and Irinotecan/Cisplatin Sequenced with Etoposide for Extensive Stage Small Cell Lung Cancer

PURPOSE: Sequence dependent improved efficacy of topoisomerase I followed by topoisomerase 2 inhibitors was assessed in a randomized phase II study in extensive-stage small cell lung cancer (SCLC). METHODS: Patients with previously untreated extensive stage SCLC with measurable disease, ECOG perform...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Chemother Pharmacol
Hoofdauteurs: Owonikoko, Taofeek K., Aisner, Joseph, Wang, Xin Victoria, Dahlberg, Suzanne E., Rubin, Eric H., Ramalingam, Suresh S., Gounder, Murugesan, Rausch, Paul Gregory, Axelrod, Rita S., Schiller, Joan H.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2013
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4705842/
https://ncbi.nlm.nih.gov/pubmed/24288121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2338-z
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items